Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 1
2001 1
2003 1
2005 1
2006 3
2007 1
2008 3
2009 1
2010 2
2011 5
2012 2
2013 1
2014 5
2015 4
2018 2
2021 1
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Systemic treatments for thymoma and thymic carcinoma: A systematic review.
Berghmans T, Durieux V, Holbrechts S, Jungels C, Lafitte JJ, Meert AP, Moretti L, Ocak S, Roelandts M, Girard N. Berghmans T, et al. Among authors: roelandts m. Lung Cancer. 2018 Dec;126:25-31. doi: 10.1016/j.lungcan.2018.10.018. Epub 2018 Oct 18. Lung Cancer. 2018. PMID: 30527189 Review.
[Radiotherapy indications for non-malignant diseases in 2014].
Van Houtte P, Roelandts M, Kantor G. Van Houtte P, et al. Among authors: roelandts m. Cancer Radiother. 2014 Oct;18(5-6):425-9. doi: 10.1016/j.canrad.2014.06.015. Epub 2014 Sep 16. Cancer Radiother. 2014. PMID: 25216586 Review. French.
[Role of radiotherapy in benign diseases].
Kantor G, Van Houtte P, Beauvois S, Roelandts M. Kantor G, et al. Among authors: roelandts m. Cancer Radiother. 1997;1(5):407-16. doi: 10.1016/s1278-3218(97)89560-1. Cancer Radiother. 1997. PMID: 9587370 Review. French.
Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations.
Berghmans T, Pasleau F, Paesmans M, Bonduelle Y, Cadranel J, Cs Toth I, Garcia C, Giner V, Holbrechts S, Lafitte JJ, Lecomte J, Louviaux I, Markiewicz E, Meert AP, Richez M, Roelandts M, Scherpereel A, Tulippe Ch, Van Houtte P, Van Schil P, Wachters C, Westeel V, Sculier JP; ELCWP. Berghmans T, et al. Among authors: roelandts m. Eur Respir J. 2012 Jan;39(1):9-28. doi: 10.1183/09031936.00190310. Epub 2011 Jul 7. Eur Respir J. 2012. PMID: 21737547 Free article. Review.
[Adjuvant treatments of non-small cell lung cancer].
Moretti L, Roelandts M, Berghmans T, Van Houtte P. Moretti L, et al. Among authors: roelandts m. Cancer Radiother. 2007 Jan-Feb;11(1-2):53-8. doi: 10.1016/j.canrad.2006.05.014. Epub 2006 Jul 13. Cancer Radiother. 2007. PMID: 16843029 Review. French.
Systematic qualitative review of randomised trials conducted in nonsmall cell lung cancer with a noninferiority or equivalence design.
Paesmans M, Grigoriu B, Ocak S, Roelandts M, Lafitte JJ, Holbrechts S, Berghmans T, Meert AP, Moretti L, Danyi S, Pasleau F, Ameye L, Van Meerhaeghe A, Sculier JP. Paesmans M, et al. Among authors: roelandts m. Eur Respir J. 2015 Feb;45(2):511-24. doi: 10.1183/09031936.00092814. Epub 2014 Dec 23. Eur Respir J. 2015. PMID: 25537559 Free article. Review.
[Radiation therapy of benign diseases. What's new eight years after?].
Van Houtte P, Roelandts M, Devriendt D, Minsat M, Laharie H, Kantor G. Van Houtte P, et al. Among authors: roelandts m. Cancer Radiother. 2005 Nov;9(6-7):427-34. doi: 10.1016/j.canrad.2005.09.004. Epub 2005 Oct 10. Cancer Radiother. 2005. PMID: 16219478 Review. French.
30 results